QQQ   431.85 (+0.18%)
AAPL   169.39 (-1.91%)
MSFT   416.10 (+0.59%)
META   502.92 (+0.54%)
GOOGL   154.87 (+0.01%)
AMZN   183.74 (+0.07%)
TSLA   157.22 (-2.64%)
NVDA   870.95 (+1.27%)
AMD   163.20 (+1.80%)
NIO   3.82 (-1.80%)
BABA   69.84 (-1.10%)
T   16.08 (-0.99%)
F   12.17 (-0.49%)
MU   121.16 (-0.17%)
GE   155.69 (+1.29%)
CGC   6.88 (-1.43%)
DIS   114.19 (+1.10%)
AMC   2.71 (+9.72%)
PFE   25.84 (-0.27%)
PYPL   64.04 (+0.83%)
XOM   118.87 (-0.68%)
QQQ   431.85 (+0.18%)
AAPL   169.39 (-1.91%)
MSFT   416.10 (+0.59%)
META   502.92 (+0.54%)
GOOGL   154.87 (+0.01%)
AMZN   183.74 (+0.07%)
TSLA   157.22 (-2.64%)
NVDA   870.95 (+1.27%)
AMD   163.20 (+1.80%)
NIO   3.82 (-1.80%)
BABA   69.84 (-1.10%)
T   16.08 (-0.99%)
F   12.17 (-0.49%)
MU   121.16 (-0.17%)
GE   155.69 (+1.29%)
CGC   6.88 (-1.43%)
DIS   114.19 (+1.10%)
AMC   2.71 (+9.72%)
PFE   25.84 (-0.27%)
PYPL   64.04 (+0.83%)
XOM   118.87 (-0.68%)
QQQ   431.85 (+0.18%)
AAPL   169.39 (-1.91%)
MSFT   416.10 (+0.59%)
META   502.92 (+0.54%)
GOOGL   154.87 (+0.01%)
AMZN   183.74 (+0.07%)
TSLA   157.22 (-2.64%)
NVDA   870.95 (+1.27%)
AMD   163.20 (+1.80%)
NIO   3.82 (-1.80%)
BABA   69.84 (-1.10%)
T   16.08 (-0.99%)
F   12.17 (-0.49%)
MU   121.16 (-0.17%)
GE   155.69 (+1.29%)
CGC   6.88 (-1.43%)
DIS   114.19 (+1.10%)
AMC   2.71 (+9.72%)
PFE   25.84 (-0.27%)
PYPL   64.04 (+0.83%)
XOM   118.87 (-0.68%)
QQQ   431.85 (+0.18%)
AAPL   169.39 (-1.91%)
MSFT   416.10 (+0.59%)
META   502.92 (+0.54%)
GOOGL   154.87 (+0.01%)
AMZN   183.74 (+0.07%)
TSLA   157.22 (-2.64%)
NVDA   870.95 (+1.27%)
AMD   163.20 (+1.80%)
NIO   3.82 (-1.80%)
BABA   69.84 (-1.10%)
T   16.08 (-0.99%)
F   12.17 (-0.49%)
MU   121.16 (-0.17%)
GE   155.69 (+1.29%)
CGC   6.88 (-1.43%)
DIS   114.19 (+1.10%)
AMC   2.71 (+9.72%)
PFE   25.84 (-0.27%)
PYPL   64.04 (+0.83%)
XOM   118.87 (-0.68%)

Onconova Therapeutics (ONTX) Earnings Date, Estimates & Call Transcripts

Skip Charts & View Estimated and Actual Earnings Data

ONTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ONTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Onconova Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.72) EPS
Next Year EPS Consensus Estimate: ($0.86) EPS

ONTX Earnings Date and Information

Onconova Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Onconova Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/20/2024
Estimated)
------- 
11/14/2023Q3 2023($0.26)($0.23)+$0.03($0.23)$0.06 million$0.06 million
8/10/2023Q2 2023($0.29)($0.20)+$0.09($0.20)$0.06 million$0.06 million    
5/15/2023Q1 2023($0.27)($0.28)($0.01)($0.28)$0.06 million$0.06 million
3/16/2023Q4 2022($0.27)($0.26)+$0.01($0.26)$0.08 million$0.06 million
11/14/2022Q3 2022($0.21)($0.26)($0.05)($0.26)$0.06 million$0.06 million
8/11/2022Q2 2022($0.20)($0.19)+$0.01($0.19)$0.06 million$0.06 million    
5/11/2022Q1 2022($0.18)($0.20)($0.02)($0.20)$0.06 million$0.06 million    
3/17/2022Q4 2021-($0.16)($0.16)($0.16)$0.08 million$0.06 million    
11/11/2021Q3 2021($0.33)($0.22)+$0.11($0.22)$0.06 million$0.06 million    
8/12/2021Q2 2021($0.28)($0.27)+$0.01($0.27)$0.04 million$0.06 million    
5/17/2021Q1 2021($0.45)($0.30)+$0.15($0.02)$0.06 million$0.06 million  

Onconova Therapeutics Earnings - Frequently Asked Questions

When is Onconova Therapeutics's earnings date?

Onconova Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on ONTX's earnings history.

How much revenue does Onconova Therapeutics generate each year?

Onconova Therapeutics (NASDAQ:ONTX) has a recorded annual revenue of $230,000.00.

How much profit does Onconova Therapeutics generate each year?

Onconova Therapeutics (NASDAQ:ONTX) has a recorded net income of -$18.96 million. ONTX has generated -$0.91 earnings per share over the last four quarters.

What is Onconova Therapeutics's EPS forecast for next year?

Onconova Therapeutics's earnings are expected to decrease from ($0.72) per share to ($0.86) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ONTX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners